Marketing Campaigns Driving Growth in the US Neuromodulation Device Market

According to a new report entitled US Markets for Neuromodulation Devices 2006, this market will experience significant growth over the next five years, rising from over $1.1 billion in 2005 to nearly $3.0 billion by 2010.

Waltham, MA (PRWEB) September 18, 2006 -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that growth in the US neuromodulation device market will be due in part to a strong increase in demand as companies target both physicians and the general public with marketing and advertising campaigns. This market, comprising spinal cord stimulators, implantable drug pumps, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric electric stimulators, will also benefit from the introduction and adoption of new, higher priced devices with superior features. According to a new report entitled US Markets for Neuromodulation Devices 2006, this market will experience significant growth over the next five years, rising from over $1.1 billion in 2005 to nearly $3.0 billion by 2010.

Spinal cord stimulators comprise conventional and rechargeable implantable pulse generators and radio frequency (RF) systems. These devices are implanted to treat chronic pain and can potentially be used to treat angina pain and chronic migraines. Over the next five years, the market for spinal cord stimulators will shift from conventional devices to rechargeable devices. Rechargeable devices have a longer life span than conventional devices and can be operated at a higher level of power, thus providing more pain relief. Additionally, with the use of rechargeable devices, patients are not required to wear an external component, as they are with RF systems. As a result, by 2010 rechargeable systems will constitute the largest segment of the spinal cord stimulation market, and RF systems will no longer be sold in the US.

MRG’s US Markets for Neuromodulation Devices 2006 report covers several key industry competitors, including Medtronic (MDT); Advanced Neuromodulation Systems, a subsidiary of St. Jude Medical (STJ); Cyberonics (CYBX), Advanced Bionics, owned by Boston Scientific (BSX); and Codman, a Johnson & Johnson company (JNJ).

About Spinal Cord Stimulators
Spinal cord stimulators are used to treat chronic pain. In spinal cord stimulation, a pulse generator is implanted—typically in the hip area—and leads are inserted into the epidural space of the spine and connected to the pulse generator by flexible extensions, which accommodate patient movement. After the system is implanted, the physician programs the pulse generator to deliver the appropriate level of stimulation.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101

# # #